Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
September 05, 2023 18:41 ET
|
Medexus Pharmaceuticals, Inc.
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...